Efficacy of ultrasound-guided Platelet Rich Plasma injection to promote recovery in athletes with ankle syndesmosis injury. A pilot study

Not Applicable

• Conditions: Ankle Syndesmosis Sprain; Injuries and Accidents - Other injuries and accidents; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12614000055606
• Lead Sponsor: Dr David Samra

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

All players (male and female) aged 16 and over from football clubs competing in the Sydney Rugby Union Premiership Competition (all grades and levels) with acute ankle injury and signs of possible syndesmosis injury may participate in the study. They will require MRI confirmed ankle syndesmosis injury to be eligible for enrolment.

Exclusion Criteria

-previous ankle surgery
-inter-current injury that causes more prolonged or severe disability, as judged by medical staff e.g.) knee injury requiring surgery and 6 months rehab
-non-syndesmosis related injury
-fracture of the foot or ankle
-concurrent grade 3 ATFL (anterior talofibular ligament) injury
-osteochondral defect
-tibiofibular separation by 4mm on MRI at the level of the talar dome
-pregnancy (all female participants of childbearing age will require a medical clearance including a urinary pregnancy test at screening)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Return to function - including return to normal activity, training and match-play. Return to match-play will be recorded as the first competitive match played by the athlete.[Subjects will be followed up for 12 months or until they return to match-play if less than 1 year.]